ArticleBritish journal of cancer2023

Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy.

Luca Licata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.